Immunotherapeutic strategies for each breast cancer subtype

被引：0
|
作者：
Hara, Fumikata [1 ]
机构：
[1] Japanese Fdn Canc Res Canc Inst Hosp, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.05.465
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY14-3
引用
收藏
页码：S438 / S438
页数：1
相关论文
共 50 条
  • [41] Deep Into Breast Cancer Heterogeneity to Increase Immunotherapeutic Effectiveness
    Romero-Cordoba, Sandra
    Tagliabue, Elda
    Triulzi, Tiziana
    Bianchi, Francesca
    JCO PRECISION ONCOLOGY, 2020, 4 : 1267 - 1268
  • [42] Current Approaches in Development of Immunotherapeutic Vaccines for Breast Cancer
    Allahverdiyev, Adil
    Tari, Gamze
    Bagirova, Melahat
    Abamor, Emrah Sefik
    JOURNAL OF BREAST CANCER, 2018, 21 (04) : 343 - 353
  • [43] The Prognostic Effect of Changes in Tumor Stage and Nodal Status After Neoadjuvant Chemotherapy in Each Primary Breast Cancer Subtype
    Hayashi, Naoki
    Takahashi, Yuko
    Matsuda, Naoko
    Tsunoda, Hiroko
    Yoshida, Atsushi
    Suzuki, Koyu
    Nakamura, Seigo
    Yamauchi, Hideko
    CLINICAL BREAST CANCER, 2018, 18 (02) : E219 - E229
  • [44] Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis
    Naoki Niikura
    Naoki Hayashi
    Norikazu Masuda
    Seiki Takashima
    Rikiya Nakamura
    Ken-ichi Watanabe
    Chizuko Kanbayashi
    Mayumi Ishida
    Yasuo Hozumi
    Michiko Tsuneizumi
    Naoto Kondo
    Yoichi Naito
    Yayoi Honda
    Akira Matsui
    Tomomi Fujisawa
    Risa Oshitanai
    Hiroyuki Yasojima
    Yutaka Tokuda
    Shigehira Saji
    Hiroji Iwata
    Breast Cancer Research and Treatment, 2014, 147 : 103 - 112
  • [45] Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis
    Niikura, Naoki
    Hayashi, Naoki
    Masuda, Norikazu
    Takashima, Seiki
    Nakamura, Rikiya
    Watanabe, Ken-ichi
    Kanbayashi, Chizuko
    Ishida, Mayumi
    Hozumi, Yasuo
    Tsuneizumi, Michiko
    Kondo, Naoto
    Naito, Yoichi
    Honda, Yayoi
    Matsui, Akira
    Fujisawa, Tomomi
    Oshitanai, Risa
    Yasojima, Hiroyuki
    Tokuda, Yutaka
    Saji, Shigehira
    Iwata, Hiroji
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 147 (01) : 103 - 112
  • [46] Immunotherapy in breast cancer: the subtype story
    Luen, Stephen J.
    Loi, Sherene
    CANCER FORUM, 2016, 40 (03) : 40 - 47
  • [47] Unexpected features of breast cancer subtype
    Liu, Ye-huan
    Wang, Ou-chen
    Chen, En-dong
    Cai, Ye-feng
    Pan, Chuan-meng
    Yang, Fan
    Zhang, Xiao-hua
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
  • [48] Unexpected features of breast cancer subtype
    Ye-huan Liu
    Ou-chen Wang
    En-dong Chen
    Ye-feng Cai
    Chuan-meng Pan
    Fan Yang
    Xiao-hua Zhang
    World Journal of Surgical Oncology, 13
  • [49] Immunotherapeutic strategies in lymphomas
    Engert, A
    Schnell, R
    Barth, S
    Diehl, V
    INTERNIST, 1997, 38 (02): : 150 - 156
  • [50] xCT is a new cancer stem cell immunotherapeutic target for breast cancer
    Macagno, Marco
    Lanzardo, Stefania
    Conti, Laura
    Ruiu, Roberto
    Calogero, Raffaele A.
    Cavallo, Federica
    CANCER RESEARCH, 2015, 75
12345